Rumana Ahmad | Biochemistry | Biochemistry Award

Published on by Analytical Chemistry

Dr. Rumana Ahmad | Biochemistry | Biochemistry Award

Era’s Lucknow Medical College, Era University | India

Dr. Rumana Ahmad is an accomplished biochemist specializing in molecular and biochemical parasitology, medicinal biochemistry, and translational biomedical research. Her work focuses on glutathione-S-transferase–based drug target discovery in malarial and filarial parasites, enzyme inhibition strategies, and natural product–derived therapeutics. With extensive postdoctoral experience at the University of Washington, she has contributed to prostate cancer biomarker development and advanced dialysis technologies. Her interdisciplinary research integrates enzymology, phytochemistry, molecular biology, bioinformatics, and diagnostics, supported by high-impact publications, patents, and funded projects.

Citation Metrics (Scopus)

 1500
 1000
  500
   100
     0

Citations
1,487

Documents
74

h-index
22

Citations

Documents

h-index

View Scopus Profile View ORCID Profile View Google Scholar Profile

Featured Publications

Vijaya Sarangthem | Biochemistry | Best Researcher Award

Published on by Analytical Chemistry

Dr. Vijaya Sarangthem | Biochemistry | Best Researcher Award

Research Professor | Kyungpook National University | South Korea

Dr. Sarangthem Vijaya Devi is an innovative biomedical scientist with over twelve years of expertise in biopolymer-based drug delivery, regenerative medicine, and nanotechnology, focusing on the design and development of elastin-like polypeptide (ELP)–based biomaterials for targeted therapeutics. Her doctoral research at Kyungpook National University, South Korea, involved constructing IL-4 receptor–targeting ELP systems for precise drug delivery, laying the foundation for her pioneering work in tumor-targeted cancer therapy and gene delivery. As a postdoctoral fellow, she led the development of multivalent ELP nanoparticles and depot systems, optimizing pharmacokinetics and tissue biodistribution, and establishing platforms for enhanced therapeutic efficacy. At AIIMS, New Delhi, Dr. Vijaya Devi advanced regenerative medicine applications by developing self-assembling ELP hydrogels and 3D scaffolds for mesenchymal stem cell culture, differentiation, and tissue regeneration. She further integrated 3D bioprinting technologies to create artificial tissue models for high-throughput drug screening and preclinical evaluation. Her ongoing work as a visiting research professor at Kyungpook National University focuses on ELP-driven 3D culture platforms, enabling scalable and reproducible organoid and spheroid models for precision medicine. Dr. Vijaya Devi’s research portfolio includes over 16 high-impact publications, several as corresponding or first author, highlighting her contributions to nanoparticle engineering, biomaterial optimization, and translational therapeutics. She has contributed to patents on ELP-based hydrogels for tissue regeneration and nanocarriers for oncology drug delivery, demonstrating the translational potential of her work. Recognized with multiple awards, including the Best Article Award and DST Fellowship, her research bridges fundamental science with industry applications, emphasizing scalability, regulatory compliance, and interdisciplinary collaboration. Her expertise encompasses gene delivery systems, molecular imaging, biomaterials engineering, and organoid culture, making her a leading researcher in precision therapeutics. Dr. Vijaya Devi continues to drive innovations in ELP biomaterials for cancer therapy, tissue engineering, and high-throughput drug discovery, positioning her as a global leader in biomedical research and translational medicine.

Profiles : Scopus | ORCID | Google Scholar | Research Gate

Featured Publications

  • Lee, Y.-J., Hong, J., Seo, B.-Y., Lee, B.-H., Sarangthem, V.*, & Park, R.-W. (2025). Strategic optimization of nanoparticle characteristics to enhance tumor targeting and doxorubicin delivery. International Journal of Nanomedicine, 20, 6357–6378.

  • Hong, J., Sim, D., Lee, B.-H., Sarangthem, V.*, & Park, R.-W. (2024). Multifunctional elastin-like polypeptide nanocarriers for efficient miRNA delivery in cancer therapy. Journal of Nanobiotechnology, 22(1), 293.

  • Sarangthem, V., Sharma, H., Mendiratta, M., Sahoo, R. K., Park, R.-W., Kumar, L., Singh, T. D., & Mohanty, S. (2022). Application of bio-active elastin-like polypeptide on regulation of human mesenchymal stem cell behavior. Biomedicines, 10(5), 1151.

  • Sarangthem, V.*, Sharma, H., Goel, R., Ghose, S., Park, R.-W., Mohanty, S., Chaudhuri, T. K., Dinda, A. K., & Singh, T. D. (2022). Application of elastin-like polypeptide (ELP) containing extracellular matrix (ECM) binding ligands in regenerative medicine. International Journal of Biological Macromolecules.

  • Sarangthem, V., Yi, A., Kim, Y., Rehemtulla, A., Lee, B.-H., Jeon, Y. H., Singh, T. D., & Park, R.-W. (2021). Therapeutic effect of IL4 receptor targeting pro-apoptotic peptide (AP1-ELP-KLAK) in glioblastoma tumor model. International Journal of Nanomedicine, 16, 5039–5052.

 

Xiaofei Cheng | Molecular Biology | Best Research Article Award

Published on by Analytical Chemistry

Prof. Dr. Xiaofei Cheng | Molecular Biology | Best Research Article Award

Vice Dean | Northeast Agricultural University | China

Professor Xiaofei Cheng is a distinguished molecular plant pathologist and biochemist at the College of Agriculture, Northeast Agricultural University, Harbin, China. His research focuses primarily on the molecular mechanisms underlying plant-virus interactions, with a particular emphasis on host immune modulation, viral pathogenicity, and RNA virus replication and movement. Through extensive collaborative research with national and international institutes, including Agriculture and Agri-Food Canada and the National Centre for Biotechnology (CSIC, Spain), Professor Cheng has made pioneering contributions to understanding how plant viruses exploit host cellular machinery to establish successful infections. A central theme of Cheng’s research involves elucidating how RNA viruses manipulate plant immunity. His team discovered that plant viruses can hijack host phosphatases to attenuate MAPK-mediated immunity, enabling robust infection. Moreover, his studies revealed the existence of pathogen protease-activated molecular decoys, offering potential for engineering customized resistance in plants. Cheng also uncovered viral strategies to target NPR1, a master regulator of salicylic acid (SA)-mediated defense, thereby suppressing antiviral immunity. His research extends to virus-encoded small proteins, viral replication vesicle formation, and intercellular virus movement. Earlier, Cheng’s work demonstrated that sumoylation of viral RNA polymerase promotes infection by subverting NPR1-mediated immunity, and that viral suppressor proteins such as VPg can degrade key host silencing factors via autophagy pathways. With over 96 publications, 1,635 citations, and an h-index of 23 (Scopus), Professor Cheng has established himself as a leading figure in molecular plant virology and biotechnology. His findings not only deepen our understanding of host-pathogen molecular interplay but also pave the way for developing virus-resistant crop varieties, contributing significantly to global agricultural sustainability.

Profiles : Scopus | ORCID | Google Scholar | Research Gate

Featured Publications

  • Luan, Y., Jiang, X., Wang, Y., Chai, M., Li, F., Wang, A., Wu, X., & Cheng, X. (2025). A plant RNA virus hijacks a membrane-anchored dual-specificity phosphatase to attenuate MAPK-mediated immunity for robust infection. The Plant Cell.

  • Fan, X., Zhao, Y., Ji, W., Rodamilans, B., Simón-Mateo, C., García, J. A., Wu, X., & Cheng, X.* (2025). A pathogen protease-activated molecular decoy for customized resistance in plant. Plant Biotechnology Journal, 23, 2403–2405.

  • Jiang, X., Yang, Y., Li, Y., Wang, Y., Rodamilans, B., Ji, W., Wu, X., García, J. A., Wu, X., & Cheng, X. (2025). Plant viruses convergently target NPR1 with various strategies to suppress salicylic acid-mediated antiviral immunity. Journal of Integrative Plant Biology, 67(5), 1395–1412.

  • Chai, M., Li, L., Li, Y., Yang, Y., Wang, Y., Jiang, X., Luan, Y., Li, F., Cui, H., Wang, A., Xiang, W., Wu, X., & Cheng, X.* (2024). The 6-kilodalton peptide 1 in plant viruses of the family Potyviridae is a viroporin. Proceedings of the National Academy of Sciences of the United States of America, 121(21), e2401748121.

  • Liu, J., Wu, X., Fang, Y., Liu, Y., Bello, E. O., Li, Y., Xiong, R., Li, Y., Fu, Z. Q., Wang, A., & Cheng, X.* (2023). A plant RNA virus inhibits NPR1 sumoylation and subverts NPR1-mediated plant immunity. Nature Communications, 14, 3580.

Huanhuan Song | Biochemistry | Best Researcher Award

Published on by Analytical Chemistry

Ms. Huanhuan Song | Biochemistry | Best Researcher Award

Fujian Medical University, China

👨‍🎓Profiles

🌍 Impact and Influence

Dr. Song’s research is reshaping our understanding of neuroimmune interactions. By leveraging translocator protein (TSPO)-targeted live imaging and advanced cellular models, she has revolutionized the study of microglial metabolism. Her work has broad implications, not only for MS but also for Alzheimer’s disease, Parkinson’s disease, and other neurodegenerative conditions where lipid metabolism and neuroinflammation play critical roles. Her findings have been widely cited in immunology and neuroscience literature, reflecting their significance in the field. She has presented at international immunology conferences, contributing valuable insights into novel therapeutic strategies for neuroimmune diseases.

📚 Academic Citations and Recognition

Her research findings have gained international recognition, with citations in high-impact journals focusing on immunology, neuroscience, and lipid metabolism. She actively participates in scientific conferences and symposia, sharing her insights with the global scientific community and collaborating with fellow researchers to drive progress in neuroimmune therapeutics.

🛠️ Technical Skills

Dr. Song possesses a diverse set of technical skills, including molecular and cellular immunology, animal modeling (EAE, MS models), live imaging techniques for immune responses, flow cytometry, transcriptomic analysis, CRISPR-based gene editing, lipidomics, and metabolomics in neurodegeneration research. These skills have allowed her to conduct high-impact research that bridges fundamental science with translational applications.

🎓 Teaching and Mentorship

As part of her academic role, Dr. Song is actively involved in mentoring undergraduate and master’s students in immunological techniques and experimental neuroscience. Her guidance has helped shape young researchers, fostering innovation in the field of neuroimmunology. She is dedicated to training the next generation of scientists and encouraging interdisciplinary research approaches.

🚀 Legacy and Future Contributions

Dr. Song is committed to advancing precision medicine in neuroinflammation, with future work aimed at developing novel drug interventions targeting lipid metabolism pathways. By translating fundamental research into clinical applications, she envisions creating more effective and personalized treatments for patients suffering from MS and other chronic neuroinflammatory conditions. Her pioneering research on CYP7B1 is set to leave a lasting impact on immunotherapy and neuropharmacology, making her a trailblazer in the intersection of lipid metabolism and neuroimmune regulation. With her continued contributions, Dr. Song is shaping the future of neuroinflammation research and therapeutic development.

📖Notable Publications

CYP7B1 Deficiency Impairs Myeloid Cell Activation in Autoimmune Disease of the Central Nervous System
Authors: Huanhuan Song, Aowei Lv, Zhibao Zhu, Runyun Li, Qiuping Zhao, Xintong Yu, Junyi Jiang, Xiang Lin, Cunjin Zhang, Rui Li, et al.
Journal: PNAS Nexus
Year: 2024

Tanshinone IIA Alleviates Brain Damage in a Mouse Model of Neuromyelitis Optica Spectrum Disorder by Inducing Neutrophil Apoptosis
Authors: Ye Gong, Ya-ling Zhang, Zhen Wang, Huanhuan Song, Yuan-chu Liu, Aowei Lv, Li-li Tian, Wen-li Zhu, Ying Fu, Xiao-li Ding, et al.
Journal: Journal of Neuroinflammation
Year: 2020

Fei Yao | Biochemistry | Best Researcher Award

Published on by Analytical Chemistry

Prof. Fei Yao | Biochemistry | Best Researcher Award

The First Affiliated Hospital of Guangxi Medical University, China

👨‍🎓Profiles

🎓 Early Academic Pursuits

Prof. Fei Yao’s journey in academia began with a strong foundation in biochemistry and medical sciences. With a keen interest in cancer biology, Prof. Yao pursued higher education in oncology, eventually earning a medical degree and further advancing into postdoctoral research. This rigorous academic training laid the groundwork for future contributions to cancer research.

🏥 Professional Endeavors

Currently serving as a Professor of Oncology at The First Affiliated Hospital of Guangxi Medical University, China, and The First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine, Prof. Yao has seamlessly integrated clinical expertise with research innovations. As a medical doctor and postdoctoral fellow, Prof. Yao also mentors master’s students, shaping the next generation of researchers in oncology and biochemistry.

🔬 Contributions and Research Focus

Prof. Yao’s research primarily focuses on tumor microenvironment mechanisms and the development of clinical drugs for cancer treatment. By leading multiple prestigious research projects funded by:

  • 🏅 National Natural Science Foundation of China
  • 🏅 China Postdoctoral Science Foundation
  • 🏅 Guangxi Natural Science Foundation

Prof. Yao has significantly contributed to understanding how cancer cells interact with their surroundings, paving the way for novel therapeutic strategies.

📚 Impact and Influence

Prof. Yao has published multiple SCI-indexed research papers, adding valuable insights to the field of oncology and biochemistry. These studies have not only been widely cited but have also influenced clinical applications and drug development in cancer research.

📖 Academic Citations & Recognition

With a robust research portfolio, Prof. Yao’s work has been cited extensively in international journals, reinforcing its scientific impact. These contributions continue to shape the landscape of cancer treatment and personalized medicine.

🛠️ Technical Skills & Expertise

Prof. Yao possesses expertise in various advanced biochemical and clinical research techniques, including:
✔️ Tumor Microenvironment Analysis
✔️ Cell Culture & Molecular Biology Techniques
✔️ Targeted Drug Development for Cancer
✔️ Clinical Trials & Experimental Therapies
✔️ Biostatistical Analysis & Research Methodologies

🎓 Teaching and Mentorship

As a Master’s Supervisor, Prof. Yao plays a crucial role in mentoring graduate students, guiding them in research methodologies, experimental designs, and thesis development. Many students have benefited from this mentorship, progressing in their careers as medical researchers and clinicians.

🌎 Legacy and Future Contributions

With a deep commitment to advancing cancer research, Prof. Yao aims to:
🔹 Continue exploring innovative treatments targeting the tumor microenvironment.
🔹 Bridge the gap between traditional Chinese medicine and modern oncology.
🔹 Develop next-generation clinical drugs to improve patient outcomes.
🔹 Inspire young researchers to contribute meaningfully to biochemistry and oncology.

🏆 Conclusion

Prof. Fei Yao’s dedication to biochemistry and cancer research has established a remarkable legacy in oncology, drug development, and clinical applications. As an esteemed professor, researcher, and mentor, Prof. Yao’s contributions will continue to impact the field for years to come.

📖Notable Publications

Hyperacute rejection-engineered oncolytic virus for interventional clinical trial in refractory cancer patients

Authors: L. Zhong, L. Gan, B. Wang, W. Shi, Y. Zhao

Journal: Cell

Year: 2025

Ibrahim Al-Odat | Biochemistry | Best Researcher Award

Published on by Analytical Chemistry

Dr. Ibrahim Al-Odat | Biochemistry | Best Researcher Award

Jadara University, Jordan

👨‍🎓Profiles

🎓 Early Academic Pursuits

Dr. Ibrahim A. Al-Odat began his academic journey with a B.Sc. in Applied Biological Science from the Jordan University of Science and Technology in 1999. His passion for molecular biology led him to pursue a M.Sc. in Medicine (Reproductive Health Science and Human Genetics) at the University of Sydney, completing it in 2007. He culminated his formal education with a Ph.D. in Biomedical Sciences/Molecular Biology from the University of Technology Sydney in 2016, focusing on molecular mechanisms in biomedical sciences.

💼 Professional Endeavors

He has a diverse professional background, starting as a Technical Officer at the NSW Health Department (2004-2011) in Sydney, where he honed his technical skills. He then served as a Teaching Assistant at the University of Technology Sydney from 2012 to 2017, where he contributed to various Biochemistry and pathophysiology courses. Since 2018, He has been an Assistant Professor of Molecular Biology at Jadara University in Irbid, Jordan, where he has taken an active role in teaching and research.

🧪 Contributions and Research Focus

His research primarily focuses on molecular biology and biomedical sciences. His notable research includes studying the effects of maternal cigarette smoke exposure on offspring’s health, particularly in kidney development and functionality. He has also explored the diagnostic potential of Bone Morphogenetic Protein 7 (BMP7) in renal injury and dysfunction. His research contributions are widely published and recognized in academic circles.

🌍 Impact and Influence

His work has significant implications in understanding maternal health and offspring development, particularly in the context of environmental stressors like cigarette smoke. His research has influenced the biomedical community and provided insights into potential diagnostic and therapeutic avenues for kidney-related conditions.

📚 Academic Cites

He scholarly work has garnered citations, emphasizing his contributions to the field of molecular biology and biomedical sciences. Notably, his research on maternal cigarette smoke and offspring health has been cited in numerous academic publications, showcasing its relevance and influence.

🛠️ Technical Skills

He possesses extensive technical expertise in various molecular biology techniques, including RNA, DNA, and protein extraction, Western blotting, real-time PCR, and immunohistochemistry staining. His proficiency in laboratory animal handling and statistical analysis further complements his research capabilities.

📖 Teaching Experience

He has taught a wide array of courses at Jadara University, ranging from General Biology and Molecular Biology to Clinical Biochemistry and Diagnostic Genetics. His hands-on approach extends to practical courses, where he guides students in laboratory techniques. At UTS, he contributed to courses like Pathophysiology, Pharmacology, and Analytical Biochemistry.

🏛️ Legacy and Future Contributions

His legacy lies in his commitment to education and research, fostering a new generation of scientists. His future contributions are poised to expand into deeper explorations of molecular diagnostics and therapeutic strategies, with a continued focus on maternal health and offspring development. His involvement in university committees highlights his dedication to academic governance and quality assurance.

📖Notable Publications